Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 5
2022 1
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. Meo SA, et al. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Free article. Review.
Both vaccines can cause various adverse effects, but these reactions are reported to be less frequent in the Pfizer/BioNTech vaccine compared to the Moderna COVID-19 vaccine; however, the Moderna vaccine compared to the Pfizer vaccine is easier to tran …
Both vaccines can cause various adverse effects, but these reactions are reported to be less frequent in the Pfizer/BioNTech vaccine compare …
FDA authorizes Moderna COVID-19 vaccine.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 Jan 25;63(1616):9-10. Med Lett Drugs Ther. 2021. PMID: 33512345 Review. No abstract available.
Safety outcomes associated with the moderna COVID-19 vaccine (mRNA-1273): a literature review.
Shabu A, Nishtala PS. Shabu A, et al. Expert Rev Vaccines. 2023 Jan-Dec;22(1):393-409. doi: 10.1080/14760584.2023.2209177. Expert Rev Vaccines. 2023. PMID: 37133747 Free article. Review.
INTRODUCTION: Current safety data from Phase 3 clinical trials have concluded that apart from transient local and systemic reactions, no safety concerns were identified for the Moderna COVID-19 vaccine (mRNA-1273). However, Phase 3 studies are insuffic …
INTRODUCTION: Current safety data from Phase 3 clinical trials have concluded that apart from transient local and systemic reactions, no saf …
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review.
Suhaimi SNAA, Zaki IAH, Noordin ZM, Hussin NSM, Ming LC, Zulkifly HH. Suhaimi SNAA, et al. Clin Exp Vaccine Res. 2023 Oct;12(4):265-290. doi: 10.7774/cevr.2023.12.4.265. Epub 2023 Oct 31. Clin Exp Vaccine Res. 2023. PMID: 38025914 Free PMC article. Review.
Findings revealed that VITT cases are strongly related to viral vector-based vaccines, which are the AstraZeneca COVID-19 vaccine (95%) and the Janssen COVID-19 vaccine (4%), with much rarer reports involving messenger RNA-based vaccines such as the Moderna COVID- …
Findings revealed that VITT cases are strongly related to viral vector-based vaccines, which are the AstraZeneca COVID-19 vaccine (95%) and …
Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis.
Ahmed SK, Mohamed MG, Essa RA, Ahmed Rashad EA, Ibrahim PK, Khdir AA, Wsu ZH. Ahmed SK, et al. Diabetes Metab Syndr. 2022 Jun;16(6):102513. doi: 10.1016/j.dsx.2022.102513. Epub 2022 May 27. Diabetes Metab Syndr. 2022. PMID: 35660931 Free PMC article. Review.
The median age was 29.2 years; 92.2% were male and 7.8% were female. 72.4% of patients received the Pfizer-BioNTech (BNT162b2) vaccine, 23.8% of patients received the Moderna COVID-19 Vaccine (mRNA-1273), and the rest of the 3.5% received other types o …
The median age was 29.2 years; 92.2% were male and 7.8% were female. 72.4% of patients received the Pfizer-BioNTech (BNT162b2) vaccine, 23.8 …
Characteristics of sudden hearing loss after different COVID-19 vaccinations: a systematic review and meta-analysis.
Albakri K, Abdelwahab OA, Gabra MD, Nafady MH, Alabdallat YJ, Soliman A, Cadri S, Hanaqtah B, Albazee E. Albakri K, et al. Eur Arch Otorhinolaryngol. 2023 Dec;280(12):5167-5176. doi: 10.1007/s00405-023-08172-w. Epub 2023 Aug 18. Eur Arch Otorhinolaryngol. 2023. PMID: 37594544 Review.
Of the patients, 328 out of 609 vaccinated patients took the Pfizer-BioNTech BNT162b2 vaccine, while 242 (40%) took the Moderna COVID-19 vaccine. The mean time from vaccination to hearing impairment was 6.2, ranging from a few hours to one month after …
Of the patients, 328 out of 609 vaccinated patients took the Pfizer-BioNTech BNT162b2 vaccine, while 242 (40%) took the Moderna CO …
Ten tips for improving your clinical practice during the COVID-19 pandemic.
Abrams EM, Singer AG, Greenhawt M, Stukus D, Shaker M. Abrams EM, et al. Curr Opin Pediatr. 2021 Apr 1;33(2):260-267. doi: 10.1097/MOP.0000000000000998. Curr Opin Pediatr. 2021. PMID: 33587368 Free PMC article. Review.
Although there has been some international concern for allergic reactions to the recently approved Pfizer-BioNTech COVID-19 vaccine, neither the United States Pfizer-BioNTech or Moderna COVID-19 vaccine emergency use authorizations exclude patients wit …
Although there has been some international concern for allergic reactions to the recently approved Pfizer-BioNTech COVID-19 vaccine, neither …
Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature Review.
Liu YA, Dai J, Nagarajan P, Torres-Cabala CA, Aung PP, Prieto VG, Cho WC. Liu YA, et al. Am J Dermatopathol. 2023 Mar 1;45(3):185-188. doi: 10.1097/DAD.0000000000002369. Epub 2023 Jan 10. Am J Dermatopathol. 2023. PMID: 36626570 Review.
In this article, we describe an additional case of COVID-19 vaccination-associated PRP in a 50-year-old woman with a history of metastatic breast carcinoma, who developed a widespread cutaneous eruption characteristic of PRP, including palmoplantar keratoderma, 10 days after her …
In this article, we describe an additional case of COVID-19 vaccination-associated PRP in a 50-year-old woman with a history of metastatic b …
12 results